Factor Eight Inhibitor Bypassing Activity as First-line Therapy for Coagulopathy in Cardiac Surgery.
Sign Up to like & getrecommendations! Published in 2024 at "Journal of cardiothoracic and vascular anesthesia"
DOI: 10.1053/j.jvca.2024.05.015
Abstract: OBJECTIVES To compare the outcomes of factor eight inhibitor bypassing activity (FEIBA) versus fresh frozen plasma (FFP) as the primary treatment for postoperative coagulopathy in patients undergoing cardiac surgery. DESIGN A retrospective, propensity-matched study. SETTING… read more here.
Keywords: eight inhibitor; inhibitor bypassing; cardiac surgery; factor eight ... See more keywords
Factor eight inhibiting bypass activity for refractory bleeding in acute type A aortic dissection repair: A propensity‐matched analysis
Sign Up to like & getrecommendations! Published in 2022 at "Transfusion"
DOI: 10.1111/trf.17117
Abstract: Perioperative bleeding and transfusion have been associated with adverse outcomes after cardiac surgery. The use of factor eight inhibiting bypass activity (FEIBA) in managing bleeding after repair of acute Stanford type A aortic dissection (ATAAD)… read more here.
Keywords: bypass activity; type aortic; eight inhibiting; inhibiting bypass ... See more keywords